Last reviewed · How we verify
Nexium powder for injection and infusion 40 mg
Nexium powder for injection and infusion 40 mg is a Small molecule drug developed by isRed Pharma & Biotech Research Corporation. It is currently FDA-approved.
At a glance
| Generic name | Nexium powder for injection and infusion 40 mg |
|---|---|
| Sponsor | isRed Pharma & Biotech Research Corporation |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nexium powder for injection and infusion 40 mg CI brief — competitive landscape report
- Nexium powder for injection and infusion 40 mg updates RSS · CI watch RSS
- isRed Pharma & Biotech Research Corporation portfolio CI
Frequently asked questions about Nexium powder for injection and infusion 40 mg
What is Nexium powder for injection and infusion 40 mg?
Nexium powder for injection and infusion 40 mg is a Small molecule drug developed by isRed Pharma & Biotech Research Corporation.
Who makes Nexium powder for injection and infusion 40 mg?
Nexium powder for injection and infusion 40 mg is developed and marketed by isRed Pharma & Biotech Research Corporation (see full isRed Pharma & Biotech Research Corporation pipeline at /company/isred-pharma-biotech-research-corporation).
What development phase is Nexium powder for injection and infusion 40 mg in?
Nexium powder for injection and infusion 40 mg is FDA-approved (marketed).